BI
AZN icon

Ballast Inc’s AstraZeneca AZN Stock Holding History

Ballast Inc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Buy
+1,424
New +$268K 0.05% 137

Other funds holding AZN

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Ballast Inc's AZN Position: Q2 2026 in Review

Ballast Inc opened a new position in AstraZeneca (AZN) in Q2 2026: 1,424 shares worth $270K. The stake represents 0.05% of the portfolio and ranks #137 among its holdings.

218 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Ballast Inc held 1,424 shares of AstraZeneca worth $270K as of Q2 2026.
  • AstraZeneca was a new Ballast Inc position in Q2 2026.
  • AstraZeneca made up 0.05% of Ballast Inc's portfolio in Q2 2026, its #137 holding.
  • 218 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Ballast Inc's 13F filing for Q2 2026, filed 10 Jul 2026.